Last Updated: May 2026 SterlingMedicalCenter.org is committed to editorial transparency. This page documents the research methodology, evidence standards, review process, and independence practices that govern all content published by the SMC Research Desk.
Who We Are
The SMC Research Desk is an independent editorial operation publishing evidence-based analysis of health supplements, telehealth platforms, and wellness programs. This publication is not a medical practice and does not employ licensed healthcare professionals in a patient-care capacity. Content published here reflects research and editorial judgment applied to publicly available scientific literature, regulatory filings, and product information — not clinical evaluation of individual readers. The editorial mission of this publication is to close the gap between what health products and platforms claim and what the published clinical literature actually supports. In a market where marketing claims routinely outpace the science, the SMC Research Desk exists to give readers the evidence foundation they need to make informed decisions — and to consult qualified healthcare providers with better questions.
Evidence Hierarchy
All product and platform analyses are evaluated according to the following evidence hierarchy. The tier classification applied to any given ingredient, mechanism, or platform claim is documented within the relevant review. Tier 1 — Robust human clinical evidence: Multiple well-designed randomized controlled trials (RCTs) published in peer-reviewed journals, with consistent directional findings across independent research groups. Systematic reviews and meta-analyses of Tier 1 trials are weighted most heavily. Tier 2 — Moderate human clinical evidence: At least one well-designed human RCT with positive findings, or multiple smaller trials with generally consistent results. Meaningful evidence exists, but volume, sample size, or replication does not yet meet Tier 1 standards. Tier 3 — Preliminary or mixed human evidence: Early-stage human trial data, conflicting findings across studies, or positive results limited to specific subpopulations. The SMC Research Desk does not dismiss Tier 3 evidence — early data is still data — but clearly communicates where the science stands and what questions remain open. Tier 4 — Insufficient human evidence: Ingredients or mechanisms supported primarily by animal studies, in vitro research, or theoretical pathways without validation in human clinical trials. This tier is not a judgment of implausibility — it reflects the current state of the published evidence. Tier 5 — Manufacturer-supplied data: Unpublished proprietary studies, internal testing data, and marketing-sourced claims are treated with appropriate skepticism and clearly labeled as manufacturer assertions rather than independent findings. Proprietary studies are not accepted as equivalent to peer-reviewed published research. Not treated as evidence: Customer reviews, testimonials, social media reports, and anecdotal accounts are noted for context where relevant but are never used as evidence of efficacy or safety.
Dosage Adequacy Standards
A product's ingredient list is only part of the formulation picture. The SMC Research Desk evaluates whether ingredients are present at doses consistent with the amounts used in published clinical research. Clinically studied dosage comparison: The amount of each active ingredient in a reviewed product is compared against the doses used in human clinical trials. Material underdosing relative to research doses is documented and flagged in the review. Proprietary blend transparency: Formulations that conceal individual ingredient dosages behind proprietary blend labeling prevent dosage adequacy assessment. Proprietary blends are flagged for lack of transparency, and confidence ratings for individual ingredient dosing are adjusted accordingly. Bioavailability and ingredient form: Ingredient form affects absorption. Where published research supports meaningful bioavailability differences between ingredient forms (for example, magnesium glycinate vs. magnesium oxide, or methylfolate vs. folic acid), these distinctions are documented in the review.
Regulatory and Manufacturing Assessment
All reviewed products are assessed for compliance with applicable regulatory standards: FDA facility registration: Dietary supplement manufacturers are required to register their facilities with the FDA. Registration status is verified where disclosure is available. GMP compliance: Current Good Manufacturing Practice compliance under 21 CFR Part 111 is treated as a baseline standard for supplement manufacturing quality. Third-party testing: Independent testing by recognized organizations — including USP, NSF International, Informed Sport, and ConsumerLab — is treated as a positive quality indicator. The SMC Research Desk distinguishes between third-party testing of raw materials and testing of finished products. Enforcement history: FDA warning letters, FTC enforcement actions, and other regulatory citations relevant to a reviewed brand or manufacturer are documented and factored into the overall assessment. Regulatory status of prescription and compounded products: For telehealth platforms and prescription medication programs, the regulatory status of the medications involved — including FDA approval status, compounding pharmacy oversight, and controlled substance classification — is documented and updated when material changes occur.
Platform Evaluation Framework
Telehealth platform reviews apply a standardized assessment framework covering: Provider credentialing: Qualifications of prescribing providers, whether physician oversight exists for mid-level practitioners, and whether credential disclosure to patients occurs before consultation. Clinical assessment depth: The thoroughness of intake processes, whether medical history is reviewed before prescribing, and whether contraindications are actively screened. Pharmacy sourcing: Whether medications are dispensed through licensed U.S. pharmacies or FDA-registered compounding facilities. Monitoring protocols: Whether structured follow-up protocols exist for ongoing treatment management. Pricing transparency: Total cost disclosure including consultation fees, medication costs, subscription charges, and cancellation terms. Insurance navigation: Accuracy of insurance coverage representations and the availability of transparent cash-pay pricing.
Editorial Independence
The SMC Research Desk maintains complete editorial independence from all brands, platforms, and products reviewed on this Site. No manufacturer, advertiser, or affiliate partner has review rights, approval rights, or editorial control over any content published on SterlingMedicalCenter.org. Product manufacturers are not notified prior to publication and are not given the opportunity to alter, delay, or influence editorial conclusions. Affiliate compensation does not determine which products are reviewed, what editorial conclusions are reached, or how products are assessed. Products with active affiliate programs have received unfavorable assessments on this Site. Full affiliate disclosure practices are documented on the Affiliate Disclosure page.
Content Updates and Accuracy
Health product formulations, platform services, pricing, and regulatory status change frequently. The SMC Research Desk updates reviews when material changes warrant revision, including product reformulations, significant pricing changes, new clinical research, and regulatory developments. The “Last Updated” date on individual reviews reflects the most recent editorial update to that content. Readers should treat any review dated more than 12 months ago as potentially in need of verification against current product and regulatory information.
What This Publication Does Not Do
The SMC Research Desk does not accept payment for favorable reviews. It does not publish sponsored content without clear labeling. It does not allow affiliate relationships to influence editorial conclusions. It does not evaluate products based on marketing quality, brand partnerships, or PR submissions. It does not make individualized health recommendations or substitute for professional medical guidance.
Corrections Policy
When errors in published content are identified — whether factual inaccuracies, outdated information, or editorial misjudgments — corrections are made promptly. Material corrections are noted within the relevant content. Questions about specific content may be submitted through the Contact page.
Not Medical Advice
All content on SterlingMedicalCenter.org is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Readers should consult a qualified healthcare provider before making any health-related decision. See the Medical Disclaimer for complete details.